Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION

ConditionsEye Diseases Retinitis Pigmentosa Diabetic Retinopathy Macular Degeneration Traumatic Optic Neuropathy Optic Atrophy

Trial statusRecruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

AgeNot listed

SponsorThe Foundation for Orthopaedics and Regenerative Medicine

About this trial

This trial will study the safety and efficacy of intravenous and sub-tenon delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of non-arteritic ischemic optic neuropathy

Eligibility criteria

Qualifiers

Diagnosis of NAION (non-arteritic ischemic optic neuropathy)

Understanding and willingness to sign a written informed consent document

Disqualifiers

Active infection

Active cancer

Chronic multisystem organ failure

Pregnancy

Trial design

Treatments tested in this trial

AlloRx

Treatment groups

20 Participants

are divided into 1 treatment group

Sponsors and collaborators

The Foundation for Orthopaedics and Regenerative Medicine

Lead sponsor

Source ClinicalTrials.gov